Sagimet Biosciences Inc (NASDAQ:SGMT)’s traded shares stood at 3.17 million during the last session, with the company’s beta value hitting 2.42. At the close of trading, the stock’s price was $6.19, to imply an increase of 4.21% or $0.25 in intraday trading. The SGMT share’s 52-week high remains $7.38, putting it -19.22% down since that peak but still an impressive 72.05% since price per share fell to its 52-week low of $1.73.
Analysts have given a consensus recommendation of Buy for Sagimet Biosciences Inc (SGMT), translating to a mean rating of 1.00. Of 5 analyst(s) looking at the stock, 0 analyst(s) give SGMT a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 4 recommend it as a Buy.
Sagimet Biosciences Inc (NASDAQ:SGMT) trade information
After registering a 4.21% upside in the last session, Sagimet Biosciences Inc (SGMT) has traded red over the past five days. The 5-day price performance for the stock is 51.72%, and 87.01% over 30 days. With these gigs, the year-to-date price performance is 37.56%.
The extremes give us $6 and $6 for target low and target high price respectively. As such, SGMT has been trading 3.07% off suggested target high and 3.07% from its likely low.
SGMT Dividends
Sagimet Biosciences Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is NEA MANAGEMENT COMPANY, LLC with 2.0 million shares, or about 6.2677% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $6.84 million.
